Center for Medicare and Medicaid Innovation

CMS exec to present keynote at RISE's upcoming CMS Bid Boot Camp

Retrieved on: 
Thursday, November 9, 2023
CMS, RISE, Medicare, PBP, Center for Medicare and Medicaid Innovation, HPMS, Pharmacy, Medicaid, Centers for Medicare & Medicaid Services, Risk management

JACKSONVILLE, Fla. , Nov. 9, 2023 /PRNewswire/ -- Michael de la Guardia, VBID model co-lead, CMS Center for Medicare and Medicaid Innovation, will be the keynote speaker at RISE's CMS Bid Boot Camp, the only conference in the market dedicated to covering the entire bid process from start to finish.

Key Points: 
  • JACKSONVILLE, Fla. , Nov. 9, 2023 /PRNewswire/ -- Michael de la Guardia, VBID model co-lead, CMS Center for Medicare and Medicaid Innovation, will be the keynote speaker at RISE's CMS Bid Boot Camp , the only conference in the market dedicated to covering the entire bid process from start to finish.
  • He'll also discuss the reporting requirements for the model as well as future plans for the VBID hospice benefit component.
  • The CMS Bid Boot Camp brings together product managers, actuaries, and other CMS bid stakeholders to explore timelines, critical steps, and strategies to optimize their CMS bid.
  • The CMS Bid Boot Camp will take place January 22-23, 2024, at The Sawgrass Marriott Golf Resort & Spa, Jacksonville, Fla. Click here for the complete list of speakers, preconference workshops, the agenda, and how to register for the program.

AAHKS Grants Force Therapeutics the 2023 Industry Innovation Award

Retrieved on: 
Wednesday, November 8, 2023
Documentation, FDA, Food, Medical device, Medicare, Data collection, MD, MSK, Health, Software, RTM, Hip, Center for Medicare and Medicaid Innovation, FRCS, CPT, Centers for Medicare & Medicaid Services, Therapy, Patient, Food and Drug Administration, Automation, Force, CMS, Pharmaceutical industry

NEW YORK, Nov. 8, 2023 /PRNewswire/ -- On Friday, November 3, Force Therapeutics was presented the Industry Innovation Award by the American Association of Hip and Knee Surgeons (AAHKS) at the AAHKS Annual Meeting in Dallas, Texas.

Key Points: 
  • NEW YORK, Nov. 8, 2023 /PRNewswire/ -- On Friday, November 3, Force Therapeutics was presented the Industry Innovation Award by the American Association of Hip and Knee Surgeons (AAHKS) at the AAHKS Annual Meeting in Dallas, Texas.
  • The Industry Innovation Award is a competitive product award for companies demonstrating cutting-edge innovation in the field of orthopedic hip and knee arthroplasty.
  • "AAHKS is truly excited to grant the Industry Innovation Award to Force Therapeutics for its addition of Remote Therapeutic Monitoring (RTM) to its digital care platform.
  • Force Therapeutics' award-winning product is the addition of RTM to the Force Therapeutics digital care platform, which satisfies U.S. Food and Drug Administration (FDA) requirements as Software as a Medical Device (SaMD).

Model N Responds to Mounting Regulatory Pharma Pressures with Innovations that Ensure Compliance and Optimize Revenue

Retrieved on: 
Tuesday, November 7, 2023
Other Manufacturing, Technology, Public Policy, Government, Health Technology, Healthcare Reform, Manufacturing, Software, Health, Pharmaceutical, Model N (company), Model N, NYSE, Medicare, IRA, Center for Medicare and Medicaid Innovation, IDC, Complexity, Centers for Medicare & Medicaid Services, Inflation Reduction Act of 2022, Inflation, Service, Fine chemical

Model N (NYSE: MODN), the leader in revenue optimization and compliance today announced new product innovations geared towards the increasingly complex regulatory environment for global pharma manufacturers.

Key Points: 
  • Model N (NYSE: MODN), the leader in revenue optimization and compliance today announced new product innovations geared towards the increasingly complex regulatory environment for global pharma manufacturers.
  • Model N has made further enhancements to 340B Vigilance, one of the company’s key products for pharma manufacturers to manage 340B rebates and compliance.
  • “Manufacturers that prioritize technologies to ensure compliance and transparency, eliminate discounting errors, and monitor provider eligibility will better optimize revenue operations.
  • Model N recently added IRA-specific master data attributes to its product master data, setting manufacturers up for success with regulatory compliance and Medicare price negotiation.

InspireMD Reports Third Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Monday, November 6, 2023
CAS, Blood vessel, National coverage determination, Stroke, Medical Affairs Bureau, Nine Months, Medicare, TEL, NCD, NSPR, Global marketing, IDE, Quality assurance, EPS, CEA, Clinical trial, Risk, Myocardial infarction, Medicaid, TCAR, Center for Medicare and Medicaid Innovation, Safety, Stenosis, Investment, Patient, Death, CMS, Birth control, Medical device, Clothing, Cryptocurrency, Pharmaceutical industry, Beauty salon, Video game, Film industry, MD

TEL AVIV, Israel and MIAMI, Nov. 06, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for treatment of carotid artery disease and prevention of stroke today announced financial results and business updates for the third quarter ended September 30, 2023.

Key Points: 
  • Generated CGuard revenue for the third quarter 2023 of $1,556,072, an 8.8 % increase over the same period in 2022.
  • Sold 2,734 CGuard EPS stent systems in the third quarter of 2023, as compared to 2,624 in the third quarter of 2022, an increase of 4.2 %.
  • Total financial income for the third quarter of 2023 was $461,000, an increase of $380,000 or 469% compared to $81,000 for the third quarter of 2022.
  • Management will host a conference call today, Monday, November 6th, at 8:30 AM ET, to review financial results and provide an update on corporate developments.

ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against AdaptHealth Corp. and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, November 6, 2023
Insurance, Complaint, Medicare, Person, Telephone, Court, Diabetes, P.C, District court, Center for Medicare and Medicaid Innovation, Sleep apnea, Patient, Centers for Medicare & Medicaid Services, CMS, Security (finance), Life insurance

Investors have until December 26, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until December 26, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • AdaptHealth is a supplier of home medical equipment for chronic health conditions including diabetes, sleep apnea, and wound care.
  • To facilitate this scheme, AdaptHealth and certain of its senior executives made numerous false and misleading statements to investors during the Class Period.
  • As a result of these misrepresentations, AdaptHealth common stock traded at artificially inflated prices during the Class Period.

EXL named a Leader in Everest Group Clinical and Care Management Operations Services PEAK Matrix® Assessment 2023

Retrieved on: 
Wednesday, November 1, 2023
Nuclear Deterrence Operations Service Medal, Health care, Health, Medicare, PEAK, Data management, Risk, Partnership, CCM, Machine learning, NLP, Center for Medicare and Medicaid Innovation, Aspirants, AI, Investment, EXL, Patient, Centers for Medicare & Medicaid Services, Risk management, Retail, Mount Everest

NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- EXL, a leading data analytics and digital operations and solutions company, today announced that it has been named a Leader in the Everest Group Clinical and Care Management (CCM) Operations Services PEAK Matrix® Assessment 2023.

Key Points: 
  • NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- EXL, a leading data analytics and digital operations and solutions company, today announced that it has been named a Leader in the Everest Group Clinical and Care Management (CCM) Operations Services PEAK Matrix® Assessment 2023.
  • The Everest Group report highlights EXL’s comprehensive portfolio of healthcare analytics solutions and platforms.
  • Partnering with service providers can be a valuable way to achieve this differentiation,” said Abhishek AK, vice president at Everest Group.
  • “This recognition reinforces our commitment to helping our clients navigate a value-based care landscape with a responsive approach and partner mindset.”
    To read more about the Everest Group’s CCM Operations Services PEAK Matrix® Assessment 2023, click here .

ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against AdaptHealth Corp. and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, November 1, 2023
Insurance, Complaint, Medicare, Person, Telephone, Court, Diabetes, P.C, District court, Center for Medicare and Medicaid Innovation, Sleep apnea, Patient, Centers for Medicare & Medicaid Services, CMS, Security (finance), Life insurance

Investors have until December 26, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until December 26, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • AdaptHealth is a supplier of home medical equipment for chronic health conditions including diabetes, sleep apnea, and wound care.
  • To facilitate this scheme, AdaptHealth and certain of its senior executives made numerous false and misleading statements to investors during the Class Period.
  • As a result of these misrepresentations, AdaptHealth common stock traded at artificially inflated prices during the Class Period.

COPILOT PROVIDER SUPPORT SERVICES EXPANDS ITS E-SERVICE OFFERINGS IN ATTAINING SURESCRIPTS CERTIFICATION FOR ELECTRONIC PRIOR AUTHORIZATION SERVICES

Retrieved on: 
Monday, November 6, 2023
Policy, Medicare, HCP, Pharmacy, HUB, API, Workflow, Center for Medicare and Medicaid Innovation, EMR, Hub, Potyvirus, Communication, Centers for Medicare & Medicaid Services, CMS, Pharmaceutical industry, Mark (given name)

MAITLAND, Fla., Nov. 6, 2023 /PRNewswire/ -- COPILOT Provider Support Services, a leading HUB, now offers an updated version of AUTOPILOT – the company's proprietary electronic benefits verification (eBV) and electronic prior authorization (ePA) platform. The innovative solution empowers patient support services protocols and complies with the Centers for Medicare and Medicaid Services (CMS) industry policy.

Key Points: 
  • MAITLAND, Fla., Nov. 6, 2023 /PRNewswire/ -- COPILOT Provider Support Services , a leading HUB, now offers an updated version of AUTOPILOT – the company's proprietary electronic benefits verification (eBV) and electronic prior authorization (ePA) platform.
  • The innovative solution empowers patient support services protocols and complies with the Centers for Medicare and Medicaid Services (CMS) industry policy.
  • "Prior authorization is a known industry challenge, and HUBs are the right model to provide an efficient, automated solution for pharmacies and medical providers."
  • COPILOT has a full suite of application programming interfaces (API) that can integrate ePA solutions with electronic medical records (EMR) and practice management tools.

Aerin Medical Announces Advances for Chronic Rhinitis Treatment with New CPT® Code and Final CMS-Established Payment Rates

Retrieved on: 
Friday, November 3, 2023
Medical Supplies, Health, Medical Devices, Health Technology, Other Health, Other Science, Science, PNN, ENT, Education, Medicare, Aerin Lauder, Ear, Physician, American Medical Association, Nose, Rhinorrhea, MBA, Radiofrequency ablation, AMA, Multimedia, Congestion, Partnership, Center for Medicare and Medicaid Innovation, Allergy, CPT, Patient, Centers for Medicare & Medicaid Services, CMS, Thomas Jefferson University, Hospital, Nursing, Health insurance

The new code describes the procedure performed by ENT physicians when treating overactive nerves that drive chronic rhinitis symptoms with Aerin Medical’s RhinAer®.

Key Points: 
  • The new code describes the procedure performed by ENT physicians when treating overactive nerves that drive chronic rhinitis symptoms with Aerin Medical’s RhinAer®.
  • View the full release here: https://www.businesswire.com/news/home/20231031993246/en/
    CMS is set to implement a new CPT code that improves access to chronic rhinitis treatment with RhinAer® for patients often stuck in an unproductive cycle of care.
  • RhinAer is supported by a strong body of clinical evidence demonstrating significant, durable symptom improvement for chronic rhinitis patients.
  • Treatment with RhinAer is non-invasive and can be performed by ENT physicians in the office and outpatient surgical settings.

ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against AdaptHealth Corp. and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, October 27, 2023
Class Action Lawsuit, Professional Services, Legal, Insurance, Complaint, Medicare, Person, Telephone, Court, Diabetes, P.C, Jeanne Eagels, District court, Center for Medicare and Medicaid Innovation, Sleep apnea, Patient, Centers for Medicare & Medicaid Services, CMS, Health insurance, Life insurance

Investors have until December 26, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until December 26, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • AdaptHealth is a supplier of home medical equipment for chronic health conditions including diabetes, sleep apnea, and wound care.
  • To facilitate this scheme, AdaptHealth and certain of its senior executives made numerous false and misleading statements to investors during the Class Period.
  • As a result of these misrepresentations, AdaptHealth common stock traded at artificially inflated prices during the Class Period.